HGH FRAG- 5X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
HGH FRAG-5X | GH C-Terminal Fragment — Lipolytic | CAS: 66004-57-7
HGH Fragment 176-191 is a stabilized version of the 176–191 amino acid sequence of native GH. It selectively activates fat
metabolism (lipolysis) and inhibits new fat cell formation (lipogenesis) without the growth-promoting or glucose-affecting
properties of full HGH. One of the most targeted lipolytic peptides available.
DOSING PROTOCOL
| Parameter | Details |
|---|---|
| Dose | 250–500 mcg/day SubQ |
| Timing | Fasted state — morning or pre-workout; split AM/PM for higher doses |
| Cycle Length | 12–16 weeks |
| Reconstitution | Bacteriostatic water |
STACKING RECOMMENDATIONS
Combine with AOD 9604 (complementary lipolytic mechanisms), CJC+IPA or Tesamorelin (GH pulse support), and MOTS-c
(AMPK/mitochondrial fat oxidation). The SHRED-5X blend incorporates this compound.
NOTE: Glucose and IGF-1 neutral. No suppression of endogenous GH axis. Ideal base for any fat-loss peptide protocol.
From Collection
5AMINO-10X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
NNMT (Nicotinamide N-Methyltransferase) inhibitor. By inhibiting NNMT in adipose tissue, 5-Amino-1MQ increases intracellular NAD+ levels, activates SIRT1 and AMPK pathways, enhances energy expenditure, promotes fat cell shrinkage, and supports metabolic rate upregulation. No direct GH or IGF-1 effects.
Dosing Protocol
50–100 mg/day oral.
50 mg capsules:
- 50 mg/day = 1 capsule
- 100 mg/day = 2 capsules
Timing: Morning, with or without food.
Cycle Length: 8–12 weeks.
Critical: Daily consistency is important for optimal results. Fasting is not required. Best used alongside a calorie-controlled diet and regular exercise program to maximize metabolic and body-composition benefits.
AOD-9604 | AOD-X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
TB500
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.